Literature DB >> 24186488

Pluripotent stem cell models of human heart disease.

Alessandra Moretti1, Karl-Ludwig Laugwitz, Tatjana Dorn, Daniel Sinnecker, Christine Mummery.   

Abstract

Understanding the molecular basis of many cardiac diseases has been hampered by the lack of appropriate in vitro cell culture models that accurately reflect the human disease phenotypes. In the past few years, remarkable advances in stem cell biology have made possible this long-standing ambition-the generation of human and even patient-specific cellular models of diseases. Combined with other novel technologies in the fields of human genetics, tissue engineering, and gene-targeted manipulation, disease modeling with pluripotent stem cells has the promise to influence modern cardiovascular medicine on several fronts: molecular understanding of pathological mechanisms, early diagnosis, drug development, and effective treatment.

Entities:  

Mesh:

Year:  2013        PMID: 24186488      PMCID: PMC3808770          DOI: 10.1101/cshperspect.a014027

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  86 in total

1.  Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.

Authors:  Richard P Davis; Simona Casini; Cathelijne W van den Berg; Maaike Hoekstra; Carol Ann Remme; Cheryl Dambrot; Daniela Salvatori; Dorien Ward-van Oostwaard; Arthur A M Wilde; Connie R Bezzina; Arie O Verkerk; Christian Freund; Christine L Mummery
Journal:  Circulation       Date:  2012-05-30       Impact factor: 29.690

2.  Disease characterization using LQTS-specific induced pluripotent stem cells.

Authors:  Toru Egashira; Shinsuke Yuasa; Tomoyuki Suzuki; Yoshiyasu Aizawa; Hiroyuki Yamakawa; Tomohiro Matsuhashi; Yohei Ohno; Shugo Tohyama; Shinichiro Okata; Tomohisa Seki; Yusuke Kuroda; Kojiro Yae; Hisayuki Hashimoto; Tomofumi Tanaka; Fumiyuki Hattori; Toshiaki Sato; Shunichiro Miyoshi; Seiji Takatsuki; Mitsushige Murata; Junko Kurokawa; Tetsushi Furukawa; Naomasa Makita; Takeshi Aiba; Wataru Shimizu; Minoru Horie; Kaichiro Kamiya; Itsuo Kodama; Satoshi Ogawa; Keiichi Fukuda
Journal:  Cardiovasc Res       Date:  2012-06-27       Impact factor: 10.787

3.  Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors.

Authors:  Jose Francisco Islas; Yu Liu; Kuo-Chan Weng; Matthew J Robertson; Shuxing Zhang; Allan Prejusa; John Harger; Dariya Tikhomirova; Mani Chopra; Dinakar Iyer; Mark Mercola; Robert G Oshima; James T Willerson; Vladimir N Potaman; Robert J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

4.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells.

Authors:  Feng Lan; Andrew S Lee; Ping Liang; Veronica Sanchez-Freire; Patricia K Nguyen; Li Wang; Leng Han; Michelle Yen; Yongming Wang; Ning Sun; Oscar J Abilez; Shijun Hu; Antje D Ebert; Enrique G Navarrete; Chelsey S Simmons; Matthew Wheeler; Beth Pruitt; Richard Lewis; Yoshinori Yamaguchi; Euan A Ashley; Donald M Bers; Robert C Robbins; Michael T Longaker; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2013-01-03       Impact factor: 24.633

5.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

6.  Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.

Authors:  Ilanit Itzhaki; Leonid Maizels; Irit Huber; Amira Gepstein; Gil Arbel; Oren Caspi; Liron Miller; Bernard Belhassen; Eyal Nof; Michael Glikson; Lior Gepstein
Journal:  J Am Coll Cardiol       Date:  2012-06-27       Impact factor: 24.094

7.  Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells.

Authors:  Xin Ge; Yongming Ren; Oscar Bartulos; Min Young Lee; Zhichao Yue; Kun-Yong Kim; Wei Li; Peter J Amos; Esra Cagavi Bozkulak; Amulya Iyer; Wei Zheng; Hongyu Zhao; Kathleen A Martin; Darrell N Kotton; George Tellides; In-Hyun Park; Lixia Yue; Yibing Qyang
Journal:  Circulation       Date:  2012-08-22       Impact factor: 29.690

Review 8.  Physiological aspects of cardiac tissue engineering.

Authors:  Thomas Eschenhagen; Alexandra Eder; Ingra Vollert; Arne Hansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-11       Impact factor: 4.733

Review 9.  New lessons learned from disease modeling with induced pluripotent stem cells.

Authors:  Tamer T Onder; George Q Daley
Journal:  Curr Opin Genet Dev       Date:  2012-06-28       Impact factor: 5.578

10.  Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.

Authors:  Changsung Kim; Johnson Wong; Jianyan Wen; Shirong Wang; Cheng Wang; Sean Spiering; Natalia G Kan; Sonia Forcales; Pier Lorenzo Puri; Teresa C Leone; Joseph E Marine; Hugh Calkins; Daniel P Kelly; Daniel P Judge; Huei-Sheng Vincent Chen
Journal:  Nature       Date:  2013-01-27       Impact factor: 49.962

View more
  40 in total

1.  Differentiation of cardiomyocytes and generation of human engineered heart tissue.

Authors:  Kaja Breckwoldt; David Letuffe-Brenière; Ingra Mannhardt; Thomas Schulze; Bärbel Ulmer; Tessa Werner; Anika Benzin; Birgit Klampe; Marina C Reinsch; Sandra Laufer; Aya Shibamiya; Maksymilian Prondzynski; Giulia Mearini; Dennis Schade; Sigrid Fuchs; Christiane Neuber; Elisabeth Krämer; Umber Saleem; Mirja L Schulze; Marita L Rodriguez; Thomas Eschenhagen; Arne Hansen
Journal:  Nat Protoc       Date:  2017-05-11       Impact factor: 13.491

2.  Cardiac regeneration using HLA-matched induced pluripotent stem cells-no monkey business, but still a long and winding road ahead.

Authors:  Daniel Sinnecker
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 3.  Model systems for cardiovascular regenerative biology.

Authors:  Jessica C Garbern; Christine L Mummery; Richard T Lee
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

4.  Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro.

Authors:  Jérome Chal; Ziad Al Tanoury; Marie Hestin; Bénédicte Gobert; Suvi Aivio; Aurore Hick; Thomas Cherrier; Alexander P Nesmith; Kevin K Parker; Olivier Pourquié
Journal:  Nat Protoc       Date:  2016-09-01       Impact factor: 13.491

5.  Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.

Authors:  Andre Monteiro da Rocha; Guadalupe Guerrero-Serna; Adam Helms; Carly Luzod; Sergey Mironov; Mark Russell; José Jalife; Sharlene M Day; Gary D Smith; Todd J Herron
Journal:  J Mol Cell Cardiol       Date:  2016-09-10       Impact factor: 5.000

6.  Heart Regeneration with Embryonic Cardiac Progenitor Cells and Cardiac Tissue Engineering.

Authors:  Shuo Tian; Qihai Liu; Leonid Gnatovskiy; Peter X Ma; Zhong Wang
Journal:  J Stem Cell Transplant Biol       Date:  2015-04-20

7.  iPCS Cell Modeling of Inherited Cardiac Arrhythmias.

Authors:  Rami Shinnawi; Lior Gepstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

8.  Use of a neonatal rat system as a bioincubator to generate adult-like mature cardiomyocytes from human and mouse pluripotent stem cells.

Authors:  Gun-Sik Cho; Emmanouil Tampakakis; Peter Andersen; Chulan Kwon
Journal:  Nat Protoc       Date:  2017-09-07       Impact factor: 13.491

Review 9.  Genetic, clinical, molecular, and pathogenic aspects of the South Asian-specific polymorphic MYBPC3Δ25bp variant.

Authors:  Mohammed Arif; Pooneh Nabavizadeh; Taejeong Song; Darshini Desai; Rohit Singh; Sholeh Bazrafshan; Mohit Kumar; Yigang Wang; Richard J Gilbert; Perundurai S Dhandapany; Richard C Becker; Evangelia G Kranias; Sakthivel Sadayappan
Journal:  Biophys Rev       Date:  2020-07-12

Review 10.  Human iPSC modeling of heart disease for drug development.

Authors:  Anna P Hnatiuk; Francesca Briganti; David W Staudt; Mark Mercola
Journal:  Cell Chem Biol       Date:  2021-03-18       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.